Profil
Peter Weiler worked as Senior Director-Analysis & Research at DRI Capital, Inc. He then worked as Vice President-Business Development at BioSyent, Inc. from 2017 to 2018 and at Cipher Pharmaceuticals, Inc. from 2008 to 2017.
Mr. Weiler holds a graduate degree from the University of Western Ontario and an MBA from Richard Ivey School of Business.
Anciens postes connus de Peter Weiler
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 01/09/2018 |
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/05/2017 |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Formation de Peter Weiler
| University of Western Ontario | Graduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| BIOSYENT INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
